Proton Pump Inhibitors: Switching, Side Effects & Stopping

This guide is for patients who are already taking a PPI — or who have been prescribed one and want to understand what to do if it is not working as expected, how to switch safely, or how to stop without triggering rebound acid. For a full introduction to what PPIs are and how they work, see What Is a Proton Pump Inhibitor?. For dosage, timing, and long-term safety guidance, see our complete PPI guide.

How PPIs Work (Brief Overview)

PPIs irreversibly block the H⁺/K⁺-ATPase enzyme — the proton pump — in the stomach’s acid-secreting cells, suppressing acid production for 24 to 48 hours from a single dose. For a full explanation of the mechanism, see What Is a Proton Pump Inhibitor?

How PPIs Differ From Each Other

On paper, all five licensed PPIs are remarkably similar. They share essentially the same chemical structure, work through exactly the same mechanism, and produce broadly equivalent clinical outcomes at equivalent doses. NICE concluded that a class effect should be assumed — meaning no single PPI is inherently superior to another for most conditions.

That said, there are clinically relevant differences that matter in specific situations:

Drug interaction profile: Omeprazole and esomeprazole interact more with the CYP2C19 liver enzyme than the other three PPIs. This is particularly relevant when co-prescribing with clopidogrel (an antiplatelet medicine) — omeprazole and esomeprazole can significantly reduce clopidogrel’s effectiveness. Lansoprazole, pantoprazole, and rabeprazole are safer alternatives in this context.

Metabolism: Rabeprazole follows a different metabolic pathway from the other PPIs, making it less affected by the CYP2C19 genetic variation that causes some individuals to metabolise omeprazole less consistently. If omeprazole has not given you reliable results, rabeprazole is a clinically rational alternative.

Formulation: Lansoprazole is available as an orodispersible tablet (Zoton FasTab) that dissolves on the tongue — useful for patients who find swallowing capsules difficult.

Cost: Generic omeprazole and lansoprazole are both very low cost. Branded esomeprazole (Nexium) is considerably more expensive; generic esomeprazole is available.

Individual PPI Profiles

Five PPIs are currently licensed for use in the UK:

For a full side-by-side comparison of the three most commonly prescribed PPIs, see Omeprazole, Lansoprazole & Esomeprazole Compared.

What to Do If Your PPI Stops Working

If a PPI that previously controlled your symptoms has stopped working — or if you have started a PPI and not noticed the improvement you expected — there are several possible explanations worth discussing with your prescriber:

The dose may need adjusting. Standard doses control symptoms in most patients, but some people are rapid metabolisers of PPIs through the CYP2C19 pathway, meaning the drug is cleared before it can achieve full acid suppression at a standard dose. A higher dose, a twice-daily regimen, or switching to rabeprazole (which is less affected by this variation) can help.

A drug interaction may be reducing effectiveness. Some medicines affect how PPIs are absorbed or metabolised. If you have started a new medicine since beginning your PPI, mention this to your prescriber.

The diagnosis may need review. Not all upper gastrointestinal symptoms are caused by acid. If a PPI has not helped after a proper course, the underlying cause may not be acid-related — and a different investigation or treatment approach may be needed.

H. pylori status should be checked. If you have not previously been tested for Helicobacter pylori, a positive result can explain persistent symptoms that do not respond to acid suppression alone. Eradication therapy alongside a PPI typically resolves symptoms that PPIs alone cannot.

Can You Switch PPIs?

Yes — switching between PPIs is straightforward, safe, and a recognised clinical practice. Clinical evidence and real-world prescribing both show that patients who experience side effects on one PPI do not always experience the same effects when switched to another.

If you are not tolerating your current PPI, speak to your prescriber. Switching can be done directly without a gap in treatment — your prescriber will advise on the equivalent dose. The most common clinical reasons to switch are:

• Side effects that persist and affect quality of life
• A drug interaction — particularly clopidogrel, where you should switch away from omeprazole or esomeprazole
• Inadequate symptom control suggesting a metabolism issue (consider rabeprazole)
• Patient preference for formulation — orodispersible lansoprazole for swallowing difficulties

The one situation requiring extra caution is a previous allergic reaction. If you have experienced anaphylaxis or severe hypersensitivity to a PPI, inform your prescriber before switching — cross-reactivity between PPIs is possible, though not certain.

Managing Side Effects on a PPI

PPIs are generally well tolerated. The most common side effects — headache, loose stools, constipation, nausea, and flatulence — occur in roughly 1–2% of users and typically resolve within the first two weeks. If they persist, the practical step is to switch to a different PPI rather than stopping altogether.

Less common but clinically important effects with long-term use include low magnesium (which can cause muscle cramps and cardiac arrhythmias), vitamin B12 deficiency, and a modest increase in susceptibility to certain gastrointestinal infections including Clostridium difficile. These risks are most relevant for continuous use beyond 12 months and should be part of any annual prescriber review.

How to Stop a PPI Safely: Rebound Acid Explained

PPIs should not be stopped abruptly after a prolonged course. When the drug is withdrawn suddenly, the stomach’s proton pumps regenerate all at once, producing a temporary surge in acid — a phenomenon known as rebound acid hypersecretion. This typically peaks two to three weeks after stopping and can make heartburn return, sometimes more intensely than before treatment began. Many patients interpret this as their condition worsening and restart the PPI unnecessarily.

PPIs do not cause pharmacological dependency. Rebound acid is a physiological response to cessation, not an addiction — and it resolves within four to eight weeks. Managing it is a matter of tapering down gradually.

• Full dose → reduce to lowest effective dose
• Lowest dose → on-demand use (take only when symptoms occur)
• On-demand use → discontinue
• Optional: short course of an H2 blocker (famotidine) during the taper to bridge the gap